1

Park A et al. 10 ideas changing the world right now.  Time. 2009; 173(11). 

2

Davey Smith G et al. Genetic epidemiology and public health: hope, hype, and future prospects. Lancet. 2005 Oct 22-28;366(9495):1484-98. 

3

Vaught J et al. The evolution of biobanking best practices. Clin Chim Acta. 2012 Oct 9;413(19-20):1569-75. 

4

Hallmans G et al. Best practices for establishing a biobank. Methods Mol Biol. 2011;675:241-60. 

5

Vaught J et al. Biobanking Comes of Age: The Transition to Biospecimen Science. Annu Rev Pharmacol Toxicol. 2016;56:211-28. 

6

Somiari SB et al. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers. Adv Exp Med Biol. 2015;864:11-27.

7

Zisis K et al. Biobanking with Big Data: A Need for Developing "Big Data Metrics". Biopreserv Biobank. 2016 Oct;14(5):450-451.

8

Sudlow C et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015 Mar 31;12(3):e1001779.

9

Online publication et al. Global Biobank Directory, Tissue Banks and Biorepositories http://specimencentral.com/biobank-directory/. 

10

Vaz M et al. Ethical challenges in biobanking: moving the agenda forward in India. Indian J Med Ethics. 2014 Apr 1;11(2):79-88.

11

Zika E et al. Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics. 2008 Jun;9(6):773-81.

12

Bledsoe MJ et al. Ethical Legal and Social Issues of Biobanking: Past, Present, and Future. Biopreserv Biobank. 2017 Apr;15(2):142-147. 

13

Caulfield T et al. Genes, cells, and biobanks: Yes, there's still a consent problem. PLoS Biol. 2017 Jul 25;15(7):e2002654.

14

Tassé AM1 et al. Biobanking and deceased persons. Hum Genet. 2011 Sep;130(3):415-23.

15

De Clercq E1 et al. Returning Results in Biobank Research: Global Trends and Solutions. Genet Test Mol Biomarkers. 2017 Mar;21(3):128-131. 

16

Moodley K et al. "It's all about trust": reflections of researchers on the complexity and controversy surrounding biobanking in South Africa. BMC Med Ethics. 2016 Oct 10;17(1):57.

17

Hartlev M et al. Genomic Databases and Biobanks in Denmark. J Law Med Ethics. 2015 . 

18

NCI Best Practices for Biospecimen Resources.  https://biospecimens.cancer.gov/bestpractices/2016-NCIBestPractices.pdf. 

19

Biorepositories and Biospecimen Research Branch at national Cancer institute.  https://biospecimens.cancer.gov/default.asp. 

20

OECD et al. Guildlines on human biobanks and genetic research databases.  https://www.oecd.org/sti/biotech/44054609.pdf. 

21

Staunton C et al. Challenges in biobank governance in Sub-Saharan Africa. BMC Med Ethics. 2013 Sep 11;14:35.

22

Wei BR et al. Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization.  Clin Biochem. 2014 Mar;47(4-5):274-9.

23

Peakman T et al. Current standards for the storage of human samples in biobanks. Genome Med. 2010 Oct 5;2(10):72.

24

Adishesh M et al. Harmonisation of biobanking standards in endometrial cancer research. Br J Cancer. 2017 Aug 8;117(4):485-493. 

25

Kang HJ et al. Identification of clinical biomarkers for pre-analytical quality control of blood samples. Biopreserv Biobank. 2013 Apr;11(2):94-100.

26

Kalia M et al. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. 

27

Kenner BJ et al. Early Detection of Pancreatic Cancer: The Role of Industry in the Development of Biomarkers. Pancreas. 2017 Sep 26. doi: 10.1097 (Epub). 

28

Berger KN et al. PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene. Gene. 2017 Sep 23. pii: S0378-1119(17)30782-5.

29

D'Oronzo S et al. The role of biomarkers in the management of bone-homing malignancies. J Bone Oncol. 2017 Sep 11;9:1-9.

30

Jung K et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer. 2004 Sep 20;111(5):783-91.

31

Bhargava A et al. Epigenetic biomarkers for risk assessment of particulate matter associated lung cancer. Curr Drug Targets. 2017 Sep 10 (Epub). 

32

Chang L et al. Microsatellite Instability: A Predictive Biomarker for Cancer Immunotherapy. Appl Immunohistochem Mol Morphol. 2017 Sep 4 (Epub). 

33

Schrohl AS et al. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics. 2008 Oct;7(10):2061-6. 

34

Kinkorová J et al. Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview. EPMA J. 2016 Feb 22;7:4. 

35

Liu A et al. Biobanking for Personalized Medicine. Adv Exp Med Biol. 2015;864:55-68. 

36

Liu A et al. Developing an institutional cancer biorepository for personalized medicine. Clin Biochem. 2014 Mar;47(4-5):293-9.

37

Betsou F et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1017-25.

38

Sun S et al. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization. Front Med. 2016 Mar;10(1):104-10. 

39

Riondino S et al. Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle. Cancer Genomics Proteomics. 2015 Nov-Dec;12(6):291-9.

40

Almasi M et al. Biobanking - the First Step to Successful Liquid Biopsy Experiments. Klin Onkol. 2017 Summer;30(Supplementum2):9-12.

41

Lee S et al. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer. J Cancer. 2017 Aug 25;8(15):2974-2983. 

42

Basik M et al. Biopsies: next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol. 2013 Aug;10(8):437-50. 

43

Cervo S et al. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization. Int J Biol Markers. 2015 May 26;30(2):e243-51.

44

Bins S et al. Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies. Oncologist. 2017 Jan;22(1):33-40.